These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2020652)

  • 21. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM; Raica M; Nariţa D
    Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six cases showing radial scar/complex sclerosing lesions of the breast detected by breast cancer screening.
    Inoue S; Inoue M; Kawasaki T; Takahashi H; Inoue A; Maruyama T; Matsuda K; Kunitomo K; Murata S; Fujii H
    Breast Cancer; 2008; 15(3):247-51. PubMed ID: 18311480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraductal carcinoma of the breast.
    von Rueden DG; Wilson RE
    Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?
    Kosemehmetoglu K; Guler G
    Ann Diagn Pathol; 2010 Dec; 14(6):425-31. PubMed ID: 21074691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
    Visscher DW
    Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-needle aspiration cytology of apocrine adenosis of the breast: report on three cases.
    Watanabe K; Nomura M; Hashimoto Y; Hanzawa M; Hoshi T
    Diagn Cytopathol; 2007 May; 35(5):296-9. PubMed ID: 17427223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast carcinoma arising within fibroadenomas. Report of four observations.
    Ben Hassouna J; Damak T; Ben Slama A; Chargui R; Ben Dhiab T; Khomsi F; Gamoud A; Boussen H; Rahal K
    Tunis Med; 2007 Oct; 85(10):891-5. PubMed ID: 18236815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
    Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
    Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
    Selim AG; Ryan A; El-Ayat GA; Wells CA
    Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary and sclerosing lesions of the breast detected and biopsied by MRI: Clinical management, upgrade rate, and association with apocrine metaplasia.
    Ring NY; diFlorio-Alexander RM; Bond JS; Rosenkranz KM; Cervantes E; Sohn JH; Marotti JD
    Breast J; 2019 May; 25(3):393-400. PubMed ID: 30945398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.
    Tavassoli FA; Norris HJ
    Cancer; 1990 Feb; 65(3):518-29. PubMed ID: 2297643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.
    Fuehrer N; Hartmann L; Degnim A; Allers T; Vierkant R; Frost M; Visscher D
    Arch Pathol Lab Med; 2012 Feb; 136(2):179-82. PubMed ID: 22288965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinicopathologic study of atypical lesions of the breast further follow up.
    Ashikari R; Huvos AG; Snyder RE; Sharma R; Kirch R; Schottenfeld D
    Pathol Res Pract; 1980; 166(4):481-90. PubMed ID: 7433229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic pitfalls in fine needle aspiration cytology of atypical apocrine metaplasia in a breast lesion. A case report.
    Gupta D; Wolf JA; Rubenchik IA; Middleton LP
    Acta Cytol; 2002; 46(4):749-52. PubMed ID: 12146046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease.
    Tavassoli FA; Jones MW; Majeste RM; Bratthauer GL; O'Leary TJ
    Am J Surg Pathol; 1990 Feb; 14(2):128-33. PubMed ID: 2301698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
    Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
    Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
    Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
    Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.